Common queries on food allergy testing
As we wrap up another year of groundbreaking advances in allergy and immunology, the College has noted a surge in inquiries from fellow allergists about food allergy testing – particularly around routine panels, billing nuances, and guideline adherence. These questions, while routine for many of us, highlight the ongoing need for clear, evidence-based guidance to optimize patient outcomes and streamline clinical workflows. We’ve fielded several questions lately from members on:
- The appropriate scope of food-specific IgE panels (e.g., “How many allergens should a routine panel include?”)
- Billing and coding for tests in patients without a suggestive history (e.g., atopic dermatitis cases).
- Guideline-driven alternatives to indiscriminate screening.
These reflect broader challenges in a landscape where 50-90% of presumed food allergies may stem from non-IgE-mediated issues or unrelated symptoms. Let’s break it down with practical takeaways.
Core guidance: Prioritize history-driven testing over routine panels
The cornerstone of effective food allergy diagnosis is a thorough clinical history. Broad panel testing – often screening for dozens of foods without targeted rationale – carries risks: false positives (leading to unwarranted dietary restrictions); heightened costs; and patient anxiety. The College advises against it. (See Guideline roundup below.)
Key recommendations:
- Test selectively: Order specific IgE (blood) or skin prick tests only for foods linked to the patient’s history of IgE-mediated reactions (e.g., hives, swelling, or anaphylaxis post-ingestion). A positive test alone doesn’t confirm allergy – pair it with history for interpretation.
- Avoid screening in asymptomatic cases: For infants, children with eczema, or adults without reactions, skip panels. Early introduction (e.g., peanuts at 4-6 months for high-risk infants) is preferred over preemptive testing, per updated guidelines.
- When to proceed: If history suggests allergy, obtain tailored testing. Oral food challenges remain the gold standard for confirmation.
Pro tip: Educate patients upfront: “Testing without a reaction history often leads to more questions than answers – let’s focus on what matters for your symptoms.”
Billing & coding corner: Ensuring reimbursement without overreach
Mishandled codes can trigger denials, especially for tests without clear medical necessity. Insurance companies and MACs may have varying ICD-10 codes that they allow for specific procedures. Here’s how we suggest you code to be compliant:
| Scenario | Recommended ICD-10 Code | Rationale & Tips |
|---|---|---|
| Suspected IgE-mediated reaction (e.g., anaphylaxis to specific food) | Z91.010–Z91.018 (food allergy status) + specific food code (e.g., T78.01XA for peanut anaphylaxis) | Use symptom first (e.g., urticaria L50.0), then external cause. Bill CPT 86003 for in vitro IgE if history supports. |
| No food allergy history (e.g., atopic dermatitis testing) | L20.84 (intrinsic atopic dermatitis) | Avoid food allergy codes (e.g., Z91.01x) – they’re inappropriate without reaction evidence. Pair with Z13.9 for unspecified adverse food reaction if needed. |
| Unspecified reaction (e.g., unknown food trigger) | T78.1XXA/D (other adverse food reactions) + symptom code (e.g., R21 for rash) | Document history meticulously; insurers prioritize symptoms over presumptive allergy. |
Quick audit checklist:
- Does the chart note a reaction history? If not, reconsider testing.
- Use E/M codes alone for consults discussing avoidance of panels.
By aligning codes with guidelines, you safeguard revenue and patient trust.
Guideline roundup: What the experts say
Stay aligned with these pillars:
- ACAAI/AAAAI Joint Practice Parameter (2014 Update): Broad screening lacks evidence; select allergens based on history to avoid overdiagnosis.
- NIAID Guidelines (2010): Testing (skin prick or IgE) only for symptomatic patients – broad approaches are unsupported.
- EAACI Guidelines (2014): “Indiscriminate battery or panel testing for food-specific IgE should be avoided” (strong recommendation). (Cross-referenced in ACAAI resources.)
- Choosing Wisely (2014, Reaffirmed 2023): “Don’t perform food IgE testing without a history consistent with potential IgE-mediated food allergy.” Panels waste resources and mislead – 50-90% false positives expected. View AAFP Summary.
- ACAAI’s food allergy public information: A patient-friendly overview of food allergy, testing and management/treatment.
Use the resources in this article to help guide you in testing and coding for food allergy.
The Advocacy Council – ADVOCATING FOR ALLERGISTS AND THEIR PATIENTS.
References
Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):S1-S58. doi:10.1016/j.jaci.2010.10.007
Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014;69(8):1008-1025. doi:10.1111/all.12429 →
Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update—2014. J Allergy Clin Immunol. 2014;134(5):1016-1025.e43. doi:10.1016/j.jaci.2014.05.013
Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100(3 Suppl 3):S1-S148.
